Skip to main content
Premium Trial:

Request an Annual Quote

Time to Nominate Your Friends

Two calls for nominations are out. The deadline for the International Society for Interferon and Cytokine Research's Milstein Prize is May 1st. According to a press release, this award honors an individual "who has made outstanding contributions to research related to interferons and cytokines either in a basic or clinical field, and who has achieved international recognition as a result of those contributions."

In addition, the nomination process for the 2011 Szent-Györgyi Prize for Progress in Cancer Research has begun. This award goes to someone "who has contributed outstanding, substantial research to the fight against cancer and whose accomplishments have helped improve treatment options for cancer patients."

Speaking of awards, Bruce Alberts has won the 2010 Vannevar Bush Award for his lifetime contribution to science in the US. "We are pleased to recognize Bruce for his dedication to the creativity, openness and tolerance that define science, passion for improving the human condition and transformational and inspirational leadership in science education, international capacity building and the tireless pursuit of a 'scientific temperament' for the world," Steven Beering, the chair of the National Science Board, said in a statement. (HT: Larry Moran at Sandwalk.)

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.